Efficacy and safety of secukinumab in the treatment of chronic plaque psoriasis: A 52-weeks follow up study. (2024). Journal of Pakistan Association of Dermatologists, 34(1), 191-199. https://doi.org/10.66344/jpad.v34i1.2545